CBNPCannabiphorol
Heptyl (C7) homologue of CBN, very poorly documented: no published binding or pharmacokinetic data.
Harm-reduction warning
No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.
C₂₃H₃₀O₂
CAS 55824-14-1
- Family
- Semi-synthetic cannabinoidProvisional classification
- Molar mass
- 338.50 g/mol
Updated on
In plain terms
CBNP is a variant of cannabinol (CBN) whose side chain has seven carbons instead of five. Where products sold under this name come from is unknown: only a related acid form has been detected, tentatively, in cannabis. No study describes its effects in humans.
Receptors and activity
Pharmacology
CBNP (cannabiphorol) is the heptyl (C7) homologue of cannabinol: the same aromatic benzo[c]chromene nucleus, with a seven-carbon chain instead of five. The suffix « phorol » has denoted the heptyl series since the description of THCP and CBDP (Citti et al., 2019). In cannabis, only the corresponding acid, CBNPA, has been identified, and only putatively by high-resolution mass spectrometry, without isolation (Linciano et al., 2021). ChEMBL links 1983 rat data to this structure: by the oral route, a fall in systolic blood pressure and in spontaneous motor activity (Zaugg and Kyncl). No measurement of affinity for cannabinoid receptors, no pharmacokinetic data and no human study were found. No reliable source documents the origin of products sold under this name either. In France, it falls within the generic class of benzo[c]chromene derivatives in force since June 2024.
Key sources.
- Linciano P et al. The novel heptyl phorolic acid cannabinoids content in different Cannabis sativa L. accessions. Talanta 2021;235:122704 (new tab)PMID 34517579
- Zaugg HE, Kyncl J. New antihypertensive cannabinoids. J Med Chem 1983;26:214-217 (new tab)PMID 6827538
- ChEMBL, CHEMBL68869 (document CHEMBL1122324: activities in rats) (new tab)
- Citti C et al. A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-THC: Δ9-tetrahydrocannabiphorol. Sci Rep 2019;9:20335 (new tab)PMID 31889124
- PubChem CID 44308781 (cannabiphorol) (new tab)
- ANSM, consolidated list of substances classified as narcotics, updated 26/06/2026 (benzo[c]chromene class, annex IV) (new tab)
History
- Source
- Origin not established: no reliable source documents its natural occurrence or where products sold under this name come from; only its acid (CBNPA) has been putatively identified in cannabis
Route of preparation
Chemical process
No characterised biosynthesis. CBNP is the heptyl (C7) homologue of cannabinol. Only the corresponding acid, CBNPA, has been putatively identified by high-resolution mass spectrometry in cannabis samples, without isolation (Linciano et al., 2021).
Legal framework
- European Union
Not listed in the UN conventions; no EU-specific control measure was found. Checked on 20/10/2026.
- France
Narcotic through a generic class, without a named listing: it meets the definition of benzo[c]chromene derivatives (Annex IV, ANSM decisions of 22 May and 3 June 2024: hydroxyl at 1, alkyl chain at 3, two alkyls at 6, alkyl at 9), whose exclusion covers only CBN and CBNA, not their homologues. Checked on 20/10/2026.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Classification
Family, origin and source verification
- Family
Semi-synthetic cannabinoid › Provisional classification
- Chemistry
C7 side chain · neutral form
- Natural trace reported
Only the corresponding acid, cannabinophorolic acid (CBNPA), has been putatively identified by UHPLC-HRMS in Cannabis sativa samples, without isolation or a reference standard (Linciano 2021). No detection of neutral CBNP was found.
- Verification
Checked on 20 October 2026; some points still await human review.
- Wikipedia (English)
No dedicated article.
References
- Linciano P et al. The novel heptyl phorolic acid cannabinoids content in different Cannabis sativa L. accessions. Talanta 2021;235:122704 (new tab)PMID 34517579
- Zaugg HE, Kyncl J. New antihypertensive cannabinoids. J Med Chem 1983;26:214-217 (new tab)PMID 6827538
- ChEMBL, CHEMBL68869 (document CHEMBL1122324: activities in rats) (new tab)
- Citti C et al. A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-THC: Δ9-tetrahydrocannabiphorol. Sci Rep 2019;9:20335 (new tab)PMID 31889124
- PubChem CID 44308781 (cannabiphorol) (new tab)
- ANSM, consolidated list of substances classified as narcotics, updated 26/06/2026 (benzo[c]chromene class, annex IV) (new tab)
Identifiers
Names
- Common name
- Cannabiphorol
- IUPAC name
- 3-heptyl-6,6,9-trimethylbenzo[c]chromen-1-ol
- Other names
- CBN-C7 · CBN-heptyl
Identifiers
- Formula
- C₂₃H₃₀O₂
- CAS
- 55824-14-1
- PubChem CID
- 44308781(new tab)
- InChIKey
- HMHJWPZANYJXHX-UHFFFAOYSA-N
- SMILES
- CCCCCCCC1=
CC(= C2C(= C1) OC(C3= C2C= C(C= C3) C) (C) C) O
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.